5R2-25294-06477
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 346 / FL
- Registered
- 2021-09-12
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-09-04
Dose 1 — Moderna
-
2021-09-12
Registered in v-safe
-
2021-09-12
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-09-18
- 2021-09-25
-
2021-10-02
Dose 2 — Moderna
-
2021-10-03
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2022-01-01
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-04 | Moderna | No |
| 2 | 2021-10-02 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release